BRISBANE, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Please note that in the release issued earlier today by CareDx, Inc. (Nasdaq:CDNA), the media briefing and analyst and investor event schedules contained incorrect information when referencing Eastern Time. The corrected information follows:
A media briefing, “Further Advancements of Cell-Free DNA as an Important Biomarker for Transplant Recipients – CARGO II and Beyond” will take place on Thursday, April 16th, beginning at 8:00 a.m. PT (11:00 a.m. ET, 5:00 p.m. CEST). Additionally, an analyst and investor event, “The CareDx Cell-Free DNA Program – Updates from ISHLT” will also take place on April 16th, beginning at 8:30 a.m. PT (11:30 a.m. ET, 5:30 p.m. CEST). A live audio webcast for both events will be available on the Investor section of the CareDx website: www.caredx.com. Interested parties may participate by dialing (855) 420-0616 for US-domestic callers or (678) 304-6848 for international callers, please provide Conference ID: 22982776 when asked to be placed into the call.
CONTACT: CareDx, Inc. Bradley P. Sherrill Senior Director, Marketing bsherrill@CareDx.com 415-287-2397 Westwicke Partners, LLC Leigh J. Salvo Principal Tel: 415-513-1281 leigh.salvo@westwicke.com
Help employers find you! Check out all the jobs and post your resume.
